Action of L-dopa, norepinephrine and amantadine on ulcers caused by reserpine in the rat.
D000284:Administration, Oral; D000547:Amantadine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D007035:Hypothermia / Q000139:chemically induced / Q000188:drug therapy; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008297:Male; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010653:Phenylbutazone / Q000633:toxicity; D051381:Rats; D012110:Reserpine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000633:toxicity*; D013276:Stomach Ulcer / Q000139:chemically induced / Q000188:drug therapy*; D013997:Time Factors
D004295:Dihydroxyphenylalanine; D012110:Reserpine; D000547:Amantadine; D010653:Phenylbutazone; D009638:Norepinephrine